# Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-oxaliplatin-and-capecitabine-and-bevacizumab-without-radiotherapy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Keisuke Uehara,Kazuhiro Hiramatsu,Atsuyuki Maeda,Eiji Sakamoto,M. Inoue,Satoshi Kobayashi,Y. Tojima,Yuichiro Yoshioka,G. Nakayama,Hiroshi Yatsuya,Naoki Ohmiya,Hidemi Goto,Masato Nagino |
| Citations | 144 |
| DOI | 10.1093/jjco/hyt115 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/jjco/article-pdf/43/10/964/5151863/hyt115.pdf |
| OpenAlex ID | https://openalex.org/W2158696071 |
| PMID | 23935207 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Satoshi Kobayashi](https://scholariq.org/researchers/satoshi-kobayashi/)

## Paper primary topic

- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)

## Paper topics

- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.